4.4 Review

Bevacizumab in the treatment of metastatic colorectal cancer: Safety profile and management of adverse events

Journal

SEMINARS IN ONCOLOGY
Volume 33, Issue 5, Pages S26-S34

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.seminoncol.2006.08.001

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available